Skip to main content
Premium Trial:

Request an Annual Quote

Paul Holt

Paul Holt, chief financial officer of NantHealth, will resign from his position effective Sept. 11. According to a filing with the US Securities and Exchange Commission, it is an amicable split, done for unspecified personal reasons. Holt will assume an advisory role during a transition period through Dec. 31, the company said.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.